retatrutide expanded access program The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have Retatrutide Severe Obesity Trial Shows

Efficacy is similar, though oral absorption requires strict dosing rules and higher amounts of the active drug

This is not a failureits your body adapting

You may be a good candidate if: You meet BMI and/or metabolic criteria commonly used in medical weight management Youve already tried structured lifestyle changes and still struggle You are under the care of a primary physician Youre willing to have labs and regular follow-ups You understand these medications are medical tools, not cosmetic quick fixes You may not be a good candidate if you have a disordered eating history, are pregnant or breastfeeding, have specific endocrine or gastrointestinal diseases, or want a set it and forget it solution

Retatrutide has the potential for use in research on obesity.

Losing weight without protecting muscle can leave a patient smaller but weaker, more fatigued, and more vulnerable to regain

If you drive and are taking GLP-1 therapy with insulin or sulfonylureas, be aware of hypoglycaemia risk and follow DVLA guidance